How do American Water Works and Organon & Co. compare by revenue?

American Water Works reported revenue of $1.3B in Q4 FY2025, while Organon & Co. reported $1.5B in Q4 FY2025. Organon & Co. is 1.2× larger by last-quarter revenue.

Which is growing revenue faster, American Water Works or Organon & Co.?

American Water Works's latest revenue grew 5.8% year-over-year, versus -5.3% for Organon & Co.. American Water Works is growing faster on a YoY basis.

Which has a higher net margin, American Water Works or Organon & Co.?

American Water Works's net margin is 18.7% vs Organon & Co.'s -13.6%. American Water Works has the higher bottom-line margin.

Which generates more free cash flow, American Water Works or Organon & Co.?

American Water Works generated $-385.0M of free cash flow last quarter, versus $96.0M for Organon & Co.. Free cash flow is operating cash flow minus capital expenditure — what's actually left for dividends, buybacks and debt repayment.

What is the 2-year revenue CAGR for American Water Works vs Organon & Co.?

Over the trailing 8 quarters, American Water Works compounded revenue at roughly 12.6% per year, versus -3.6% for Organon & Co.. American Water Works has the faster medium-term growth trajectory.

Where does this AWK vs OGN data come from?

All figures are parsed directly from SEC EDGAR 10-Q / 10-K / 20-F / 6-K filings (for US-listed issuers) or EDINET filings (for Japanese issuers), then normalised into a common schema. Numbers update automatically as new filings are released.

vs

Side-by-side financial comparison of American Water Works (AWK) and Organon & Co. (OGN). Click either name above to swap in a different company.

Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $1.3B, roughly 1.2× American Water Works). American Water Works runs the higher net margin — 18.7% vs -13.6%, a 32.3% gap on every dollar of revenue. On growth, American Water Works posted the faster year-over-year revenue change (5.8% vs -5.3%). Organon & Co. produced more free cash flow last quarter ($96.0M vs $-385.0M). Over the past eight quarters, American Water Works's revenue compounded faster (12.6% CAGR vs -3.6%).

American Water WorksAWKEarnings & Financial Report

NYSE · Utilities · Regulated Water

American Water Works Company, Inc., through its subsidiaries, provides water and wastewater services in the United States. It offers water and wastewater services to approximately 1,700 communities in 14 states serving approximately 3.4 million active customers. The company serves residential customers; commercial customers, including food and beverage providers, commercial property developers and proprietors, and energy suppliers; fire service and private fire customers; industrial customers...

Organon & Co.OGNEarnings & Financial Report

NYSE · Health Care · Pharmaceutical Preparations

Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.

AWK vs OGN — Head-to-Head

Bigger by revenue

OGN

1.2× larger

$1.5B

$1.3B

Growing faster (revenue YoY)

AWK

+11.2% gap

5.8%

-5.3%

Higher net margin

AWK

32.3% more per $

18.7%

-13.6%

More free cash flow

OGN

$481.0M more FCF

$96.0M

$-385.0M

Faster 2-yr revenue CAGR

AWK

Annualised

12.6%

-3.6%

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric	AWK	OGN
Revenue	$1.3B	$1.5B
Net Profit	$238.0M	$-205.0M
Gross Margin	—	49.2%
Operating Margin	31.9%	-9.8%
Net Margin	18.7%	-13.6%
Revenue YoY	5.8%	-5.3%
Net Profit YoY	-0.4%	-288.1%
EPS (diluted)	$1.22	$-0.78

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue

AWK

OGN

Q4 25	$1.3B	$1.5B
Q3 25	$1.5B	$1.6B
Q2 25	$1.3B	$1.6B
Q1 25	$1.1B	$1.5B
Q4 24	$1.2B	$1.6B
Q3 24	$1.3B	$1.6B
Q2 24	$1.1B	$1.6B
Q1 24	$1.0B	$1.6B

Net Profit

AWK

OGN

Q4 25	$238.0M	$-205.0M
Q3 25	$379.0M	$160.0M
Q2 25	$289.0M	$145.0M
Q1 25	$205.0M	$87.0M
Q4 24	$239.0M	$109.0M
Q3 24	$350.0M	$359.0M
Q2 24	$277.0M	$195.0M
Q1 24	$185.0M	$201.0M

Gross Margin

AWK

OGN

Q4 25	—	49.2%
Q3 25	—	53.5%
Q2 25	—	54.8%
Q1 25	—	55.6%
Q4 24	—	56.3%
Q3 24	—	58.3%
Q2 24	—	58.4%
Q1 24	—	59.0%

Operating Margin

AWK

OGN

Q4 25	31.9%	-9.8%
Q3 25	42.2%	15.2%
Q2 25	38.4%	14.4%
Q1 25	32.7%	6.7%
Q4 24	33.3%	8.1%
Q3 24	40.9%	13.1%
Q2 24	39.4%	14.6%
Q1 24	32.5%	14.5%

Net Margin

AWK

OGN

Q4 25	18.7%	-13.6%
Q3 25	26.1%	10.0%
Q2 25	22.7%	9.1%
Q1 25	18.1%	5.8%
Q4 24	19.9%	6.8%
Q3 24	26.4%	22.7%
Q2 24	24.3%	12.1%
Q1 24	18.4%	12.4%

EPS (diluted)

AWK

OGN

Q4 25	$1.22	$-0.78
Q3 25	$1.94	$0.61
Q2 25	$1.48	$0.56
Q1 25	$1.05	$0.33
Q4 24	$1.22	$0.42
Q3 24	$1.80	$1.38
Q2 24	$1.42	$0.75
Q1 24	$0.95	$0.78

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric	AWK	OGN
Cash + ST InvestmentsLiquidity on hand	$98.0M	$574.0M
Total DebtLower is stronger	$12.8B	$8.6B
Stockholders' EquityBook value	$10.8B	$752.0M
Total Assets	$35.4B	$12.9B
Debt / EquityLower = less leverage	1.18×	11.49×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments

AWK

OGN

Q4 25	$98.0M	$574.0M
Q3 25	$166.0M	$672.0M
Q2 25	$94.0M	$599.0M
Q1 25	$114.0M	$547.0M
Q4 24	$96.0M	$675.0M
Q3 24	$127.0M	$763.0M
Q2 24	$48.0M	$704.0M
Q1 24	$584.0M	$575.0M

Total Debt

AWK

OGN

Q4 25	$12.8B	$8.6B
Q3 25	$13.0B	$8.8B
Q2 25	$12.3B	$8.9B
Q1 25	$13.3B	$9.0B
Q4 24	$12.5B	$8.9B
Q3 24	$12.6B	$8.7B
Q2 24	$12.6B	$8.7B
Q1 24	$12.6B	$8.7B

Stockholders' Equity

AWK

OGN

Q4 25	$10.8B	$752.0M
Q3 25	$10.9B	$906.0M
Q2 25	$10.7B	$733.0M
Q1 25	$10.5B	$542.0M
Q4 24	$10.3B	$472.0M
Q3 24	$10.4B	$493.0M
Q2 24	$10.2B	$144.0M
Q1 24	$10.0B	$48.0M

Total Assets

AWK

OGN

Q4 25	$35.4B	$12.9B
Q3 25	$34.7B	$13.6B
Q2 25	$33.9B	$13.5B
Q1 25	$33.2B	$13.2B
Q4 24	$32.8B	$13.1B
Q3 24	$31.8B	$12.8B
Q2 24	$31.2B	$12.2B
Q1 24	$31.1B	$11.9B

Debt / Equity

AWK

OGN

Q4 25	1.18×	11.49×
Q3 25	1.19×	9.74×
Q2 25	1.15×	12.14×
Q1 25	1.26×	16.52×
Q4 24	1.21×	18.81×
Q3 24	1.21×	17.75×
Q2 24	1.24×	60.11×
Q1 24	1.26×	181.54×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric	AWK	OGN
Operating Cash FlowLast quarter	$663.0M	$141.0M
Free Cash FlowOCF − Capex	$-385.0M	$96.0M
FCF MarginFCF / Revenue	-30.3%	6.4%
Capex IntensityCapex / Revenue	82.5%	3.0%
Cash ConversionOCF / Net Profit	2.79×	—
TTM Free Cash FlowTrailing 4 quarters	$-1.1B	$538.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow

AWK

OGN

Q4 25	$663.0M	$141.0M
Q3 25	$764.0M	$264.0M
Q2 25	$301.0M	$220.0M
Q1 25	$331.0M	$75.0M
Q4 24	$639.0M	$390.0M
Q3 24	$679.0M	$141.0M
Q2 24	$345.0M	$332.0M
Q1 24	$382.0M	$76.0M

Free Cash Flow

AWK

OGN

Q4 25	$-385.0M	$96.0M
Q3 25	$-33.0M	$218.0M
Q2 25	$-432.0M	$181.0M
Q1 25	$-217.0M	$43.0M
Q4 24	$-255.0M	$335.0M
Q3 24	$-4.0M	$99.0M
Q2 24	$-325.0M	$300.0M
Q1 24	$-227.0M	$30.0M